The global Cell Line STR Identification market size is predicted to grow from US$ 370 million in 2025 to US$ 564 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.

Verifying the identity and purity of human cell lines is essential to the integrity of research activities. Companies in the cell line authentication and characterization tests market are increasing R&D in human cell authentication assays that identify short term repeat (STR) markers. Stakeholders in the cell line authentication and characterization tests market are making use of multiplexpolymerase chain reaction(PCR) to simultaneously amplify the amelogenin gene and some of the most informative polymorphic markers in the human genome.

United States market for Cell Line STR Identification is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cell Line STR Identification is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cell Line STR Identification is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cell Line STR Identification players cover Bio-Synthesis, Inc., Cell Line Genetics, Inc., Charles River Laboratories, DNA Forensics Lab India, Eurofins Genomics (Eurofins Scientific), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information) newest research report, the ?Cell Line STR Identification Industry Forecast? looks at past sales and reviews total world Cell Line STR Identification sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Line STR Identification sales for 2025 through 2031. With Cell Line STR Identification sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Line STR Identification industry.

This Insight Report provides a comprehensive analysis of the global Cell Line STR Identification landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Line STR Identification portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cell Line STR Identification market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Line STR Identification and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Line STR Identification.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Line STR Identification market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Short Tandem Repeat (STR) Analysis
    Single Nucleotide Polymorphism (SNP) Analysis
    Others

Segmentation by Application:

    Microbial Contamination
    Cell Line Identity
    Genetic Stability
    Virus Testing
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Bio-Synthesis, Inc.
    Cell Line Genetics, Inc.
    Charles River Laboratories
    DNA Forensics Lab India
    Eurofins Genomics (Eurofins Scientific)
    GenomeScan
    IDEXX Laboratories, Inc.
    Laboratory Corporation of America Holdings
    Microsynth AG
    NorthGene Limited (Biofortuna Limited)
    Perfectus Biomed Limited
    Promega Corporation
    SGS SA
    Sigma-Aldrich Co. LLC. (Merck KGaA)
    Thermo Fisher Scientific, Inc.